James Demello

James DeMello, CPA, CA, serves as the Chief Financial Officer and Co-Founder of Dunbar Pharmaceuticals since October 2022 and deDANÚ since January 2019, while also holding the position of Chief Financial Officer and Co-Founder at Arbutus Health Group from 2018 to 2022. DeMello has extensive experience in financial leadership roles, including Tax Partner at Loen and Company from 2014 to 2019, and Co-Founder and CFO of CertiCraft from 2017 to December 2018. Previous roles include Director of Taxation and Finance at AppBridge, Staff Accountant at Sadler Weismiller Group, Account Specialist at Unilever, and Proprietary Equities Trader at Catalyst Trading Inc. DeMello's educational background includes achieving CPA Canada designation, Chartered Accountancy from the CA School of Business, and a BA in Economics from the University of Victoria.